GB0512643D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number: GB0512643D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical compounds; pharmaceutical; compounds
Prior art date: 2005-06-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

GBGB0512643.8A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Institute of Cancer Research

Astex Technology Ltd

Cancer Research Technology Ltd

Original Assignee

Institute of Cancer Research

Astex Technology Ltd

Cancer Research Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-21

Filing date

2005-06-21

Publication date

2005-07-27

2005-06-21 Application filed by Institute of Cancer Research, Astex Technology Ltd, Cancer Research Technology Ltd filed Critical Institute of Cancer Research

2005-06-21 Priority to GB0512643A priority Critical patent/GB2427406A/en

2005-07-27 Publication of GB0512643D0 publication Critical patent/GB0512643D0/en

2006-12-27 Publication of GB2427406A publication Critical patent/GB2427406A/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0816—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GB0512643A 2005-06-21 2005-06-21 Silicon-containing PKB/PKA kinase inhibitors Withdrawn GB2427406A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GB0512643A GB2427406A (en)	2005-06-21	2005-06-21	Silicon-containing PKB/PKA kinase inhibitors

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0512643A GB2427406A (en)	2005-06-21	2005-06-21	Silicon-containing PKB/PKA kinase inhibitors

Publications (2)

Publication Number	Publication Date
GB0512643D0 true GB0512643D0 (en)	2005-07-27
GB2427406A GB2427406A (en)	2006-12-27

Family

ID=34855916

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0512643A Withdrawn GB2427406A (en)	2005-06-21	2005-06-21	Silicon-containing PKB/PKA kinase inhibitors

Country Status (1)

Country	Link
GB (1)	GB2427406A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112574176A (en) *	2019-09-27	2021-03-30	隆泰申医药科技(南京) 有限公司	Heteroaryl compound and application thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0418078A8 (en)	2003-12-23	2018-01-02	Astex Therapeutics Ltd	compound or a salt, solvate, tautomer or n-oxide thereof, use of a compound, methods for the prophylaxis or treatment of an unhealthy protein kinase b-mediated condition and condition to treat a disease or condition for inhibiting a protein kinase b and a protein kinase a, to modulate a cellular process, to treat an immune disorder in a mammal and to induce apoptosis in a cancer cell, pharmaceutical composition, and process for the preparation of a compound.
JP2008546751A (en)	2005-06-22	2008-12-25	アステックス・セラピューティクス・リミテッド	Pharmaceutical composition
JP5345842B2 (en)	2005-06-23	2013-11-20	アステックス・セラピューティクス・リミテッド	Pharmaceutical combinations containing pyrazole derivatives as protein kinase modulators
GB0704932D0 (en)	2007-03-14	2007-04-25	Astex Therapeutics Ltd	Pharmaceutical compounds
US9199975B2 (en)	2011-09-30	2015-12-01	Asana Biosciences, Llc	Biaryl imidazole derivatives for regulating CYP17
US8809372B2 (en)	2011-09-30	2014-08-19	Asana Biosciences, Llc	Pyridine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU751139B2 (en) *	1997-10-13	2002-08-08	Astellas Pharma Inc.	Amide derivative
BRPI0418078A8 (en) *	2003-12-23	2018-01-02	Astex Therapeutics Ltd	compound or a salt, solvate, tautomer or n-oxide thereof, use of a compound, methods for the prophylaxis or treatment of an unhealthy protein kinase b-mediated condition and condition to treat a disease or condition for inhibiting a protein kinase b and a protein kinase a, to modulate a cellular process, to treat an immune disorder in a mammal and to induce apoptosis in a cancer cell, pharmaceutical composition, and process for the preparation of a compound.

2005
- 2005-06-21 GB GB0512643A patent/GB2427406A/en not_active Withdrawn

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112574176A (en) *	2019-09-27	2021-03-30	隆泰申医药科技(南京) 有限公司	Heteroaryl compound and application thereof
CN112574176B (en) *	2019-09-27	2024-03-15	隆泰申医药科技(南京)有限公司	Heteroaryl compound and application thereof

Also Published As

Publication number	Publication date
GB2427406A (en)	2006-12-27

Publication	Publication Date	Title
GB0501999D0 (en)	2005-03-09	Pharmaceutical compounds
GB0520657D0 (en)	2005-11-16	Pharmaceutical compounds
EP1909576A4 (en)	2010-09-01	Novel pharmaceutical compounds
ZA200703312B (en)	2008-09-25	Pharmaceutical compounds
AP2008004533A0 (en)	2008-08-31	Pharmaceutical combination
GB0520656D0 (en)	2005-11-16	Pharmaceutical compounds
IL188438A0 (en)	2008-11-03	New pharmaceutical compounds
IL181229A0 (en)	2007-07-04	Noncardiotoxic pharmaceutical compounds
ZA200804666B (en)	2010-01-27	Pharmaceutical combination
GB0512643D0 (en)	2005-07-27	Pharmaceutical compounds
ZA200705612B (en)	2009-09-30	Pharmaceutical compounds
GB0424742D0 (en)	2004-12-08	Pharmaceutical compounds
GB0428554D0 (en)	2005-02-09	Pharmaceutical compounds
GB0512246D0 (en)	2005-07-27	Novel pharmaceutical
GB0501475D0 (en)	2005-03-02	Pharmaceutical compounds
GB0512654D0 (en)	2005-07-27	Pharmaceutical compounds
GB0501310D0 (en)	2005-03-02	Pharmaceutical compounds
GB0526607D0 (en)	2006-02-08	Pharmaceutical compounds
GB0516790D0 (en)	2005-09-21	Pharmaceutical compounds
GB0516167D0 (en)	2005-09-14	Pharmaceutical compounds
GB0512681D0 (en)	2005-07-27	Pharmaceutical compounds
GB0512642D0 (en)	2005-07-27	Pharmaceutical compounds
GB0511884D0 (en)	2005-07-20	Pharmaceutical compounds
GB0510252D0 (en)	2005-06-29	Pharmaceutical compounds
GB0501480D0 (en)	2005-03-02	Pharmaceutical compounds

Legal Events

Date	Code	Title	Description
2007-11-21	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)